异丙托溴铵、沙丁胺醇雾化吸入联合甲泼尼龙治疗慢性阻塞性肺病急性加重期的临床观察
2014-06-10李戈雄肖德志陈国亮等
李戈雄 肖德志 陈国亮等
[摘要] 目的 探讨异丙托溴铵、沙丁胺醇雾化吸入联合静脉注射甲泼尼龙治疗慢性阻塞性肺病(COPD)急性加重期的临床效果。 方法 将60例COPD急性加重期患者随机分为对照组和治疗组,每组各30例。治疗组雾化吸入0.9%的氯化钠溶液2 ml+异丙托溴铵500 μg、沙丁胺醇2500 μg,2次/d,甲泼尼龙40 mg静脉注射,1次/d;对照组仅给甲泼尼龙40 mg静脉注射,1次/d。比较两组的肺功能、血气分析变化及临床疗效。 结果 治疗组的总有效率为93.3%,高于对照组的83.3%(P<0.05);治疗后,两组的FEV1、FEV1/FVC、PaO2较治疗前显著上升,PaCO2较治疗前显著下降,且治疗组的上述各指标改善情况均优于对照组(P<0.05)。 结论 异丙托溴铵、沙丁胺醇雾化吸入联合静脉注射甲泼尼龙治疗COPD急性加重期的效果好,可较快改善患者的肺功能及PaO2、PaCO2。
[关键词] 慢性阻塞性肺病急性加重期;异丙托溴铵;沙丁胺醇;甲泼尼龙
[中图分类号] R563.9 [文献标识码] A [文章编号] 1674-4721(2014)04(a)-0094-03
[Abstract] Objective To investigate clinical effect of ipratropium bromide,salbutamol for atomization inhalation combined with methylprednisolone treating chronic obstructive pulmonary disease (COPD) in an acute exacerbation period. Methods 60 patients with COPD in an acute exacerbation period were randomly divided into the control group of 30 patients and the treatment group of 30 patients.The treatment group was treated with 0.9% sodium chloride solution of 2 ml, ipratropium bromide 500 μg and salbutamol 2500 μg for atomization inhalation,2 times every day,intravenous methylprednisolone 40 mg,1 time every day;the control group was only treated with intravenous methylprednisolone 40 mg,1 time every day.Lung function,change of blood gas analysis and clinical curative effect of the two groups were compared. Results The total effective rate (93.3%) in the treatment group was higher than that in the control group (83.3%) (P <0.05);after treatment,FEV1,FEV1/FVC,PaO2 were increased significantly and PaCO2 were decreased significantly of the two groups compared with before treatment and the improvement of the indicators above-mentioned in the treatment group was better than that in the control group (P<0.05). Conclusion The effect of ipratropium bromide, salbutamol for atomization inhalation combined intravenous methylprednisolone treating COPD in acute exacerbation period,and it can rapidly improve lung function and PaO2 and PaCO2 of patients.
[Key words] Chronic obstructive pulmonary disease in an acute exacerbation period;Ipratropium bromide;Salbutamo;Methylprednisolone
慢性阻塞性肺病(chronic obstructive pulmonary disease,COPD)是一种常见的老年人慢性病,具有气流受限不完全可逆、呈进行性发展的特点,可导致肺通气和换气功能障碍引起不同程度的缺氧和二氧化碳潴留,发生不同程度的低氧血症和高碳酸血症,最终出现呼吸衰竭、慢性肺源性心脏病。COPD患者容易反复急性发作,急性加重期除针对加重的原因治疗外,还应使用支气管舒张药、糖皮质激素,舒张支气管、缓解气流受阻、减轻气道炎症、改善肺通气功能,缓解急性发作期患者的临床症状,减轻患者的痛苦。本研究采用雾化吸入异丙托溴铵、沙丁胺醇联合静脉注射甲泼尼龙治疗 COPD 急性发作期取得较好的临床效果。
1 资料与方法
1.1 一般资料
选取2011年 1 月~2013 年 10 月在本院住院的 COPD急性发作期患者 60 例,全部患者均符合COPD 急性发作期诊断标准[1]。其中,男 33例,女 27 例;年龄 56~82 岁,平均(65.8±13.7)岁。治疗前2周未使用激素,在患者知情同意的基础上,将其随机分为治疗组和对照组,各30例。……
